Comparison between 200 μg and 800 μg of vaginal misoprostol for cervical ripening before operative hysteroscopy: A randomized controlled trial.

Objective: To compare between 200 and 800 μg of vaginal misoprostol for cervical ripening before operative hysteroscopy.

Methods: Quadruple-blind randomized clinical trial conducted between November 2019 and September 2020 involving 76 patients undergoing cervical dilatation before surgical hysteroscopy at teaching hospitals in Pernambuco, Brazil. Women received the vaginal misoprostol dosage of 200 or 800 μg,10-12 h before operative hysteroscopy.

Frequency and Factors Associated with Urinary Incontinence in Pregnant Adolescents: A Cross-Sectional Study.

Study Objective: To determine the overall frequency of urinary incontinence in pregnant adolescents, focusing particularly on the presence of symptoms of stress urinary incontinence (SUI) and coital incontinence (CI), and to describe the biological, sociodemographic, clinical, urinary, reproductive, sexual, and lifestyle factors associated with incontinence.

Design: A cross-sectional, descriptive study.

Setting: The outpatient clinic for high-risk pregnancies at the Instituto de Medicina Integral Prof.

Maternal and perinatal outcomes in women with and without hypertensive syndromes submitted to induction of labor with misoprostol.

Objectives: To determine maternal and perinatal outcomes according to the mode of delivery in normotensive and hypertensive women bearing a live, full-term fetus, who were submitted to labor induction with misoprostol.

Methods: Retrospective cohort study. The endpoints were tachysystole, uterine hyperstimulation, indications for cesarean section, severe maternal morbidity, side effects, maternal death, 1st/5th minute Apgar, neonatal death, requirement for neonatal intensive care, and birth weight (grams).

Native vaginal tissue repair for genital prolapse surgical treatment: a minimum of 30 months of results.

Objective: The aim of this study was to assess the impact of using native vaginal tissue repair as a surgical treatment for pelvic organ prolapse (POP) on quality of life using validated questionnaires.

Study Design: Fifty-one women underwent surgical POP repair. All of the women were evaluated by physical examination using the POP-Q, ICIQ-VS and P-QoL questionnaires prior to surgery as well as six and at least 30 months after surgery.

Maternal near miss in the intensive care unit: clinical and epidemiological aspects.

Objective: To analyze the epidemiological clinical profile of women with maternal near miss according to the new World Health Organization criteria.

Methods: A descriptive cross-sectional study was conducted, in which the records of patients admitted to the obstetric intensive care unit of a tertiary hospital in Recife (Brazil) over a period of four years were analyzed. Women who presented at least one near miss criterion were included.

Fascial surgical repair for vaginal prolapse: effect on quality of life and related symptoms.

Objective: The aim of this study was to evaluate the impact of surgical treatment for pelvic organ prolapse (POP) on quality of life and on bladder, vaginal and bowel symptoms using validated questionnaires such as the prolapse quality of life questionnaire (P-QoL).

Study Design: Sixty-five women underwent surgical POP repair. All were evaluated by physical examination and by the use of ICIQ-VS and P-QoL questionnaires before surgery as well as three and six months after surgery.

[Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial].

Purpose: to compare the effectiveness of transdermal nitroglycerin with oral nifedipine in the inhibition of preterm delivery.

Methods: a clinical essay has been performed with 50 women in preterm delivery, randomly divided into two groups, 24 receiving oral nifedipine (20 mg), and 26, transdermal nitroglycerin (10 mg patch). Patients with a single gestation, between the 24th and the 34th weeks and diagnosis of preterm delivery were selected.

Vaginal misoprostol prior to diagnostic hysteroscopy in patients of reproductive age: a randomized clinical trial.

Study Objective: To assess pain during and after diagnostic hysteroscopy in patients of reproductive age according to use of vaginal misoprostol.

Design: A randomized, triple-masked, controlled clinical trial (Canadian Task Force classification I).

Setting: Diagnostic center at Instituto Materno Infantil de Pernambuco-Brazil.

Pain evaluation in outpatients undergoing diagnostic anesthesia-free hysteroscopy in a teaching hospital: a cohort study.

Study Objective: To evaluate and determine the main causes for pain occurrence and intensity in outpatients undergoing anesthesia-free hysteroscopy in a medical school hospital.

Design: Cohort study (Canadian Task Force classification II-2).

Setting: Diagnosis Center of the Instituto Materno-Infantil de Pernambuco.